The document discusses the development of a Laboratory Assistant Suite (LAS) database application to manage data from a preclinical cancer model experiment involving implanting patient tumor samples in mice. It provides background on using such preclinical models for personalized cancer medicine. It describes the contributions of two research institutions (IRCC and Politecnico di Torino) to the LAS project and outlines the data flow, requirements, and database design for the LAS application.
2. Players
Starting May 2011, LAS stems from the joined efforts of IRCC and the Politecnico of Torino
IRCC contribution
• Strategy
• Working- and Data-flow analysis
• User interface definition
• On-site implementation
POLITO contribution
• Database & Data warehouse
• Analytical tools & software features
• IT
4. Context – Personalized Medicine in Oncology
ASSUMPTION II:
If mutations are causative, in general terms their quality is likely to influence the behavior (biology)
of the system, in particular they are predicted to determining responses to perturbations (e.g.
drugs)
5. Context – Personalized Medicine in Oncology
ASSUMPTION III:
Mutations (or their surrogates) can be exploited to stratify patients for therapy
6. Context – Personalized Medicine in Oncology
EVIDENCE I:
Precision cancer medicine works: Selective inhibition of „driver‟ mutations can result in dramatic
clinical benefit
7. Context – Personalized Medicine in Oncology
EVIDENCE II:
a. Precision cancer medicine stands on exceptions
b. „Drivers‟ not always are „targets‟ Exceptions become rules only if confirmed on a population
basis:
• Only 10% of NSCLCs harbour EGFR mutations, and only 40% of EGFR-
mutant tumours respond to EGFR inhibitors:
• overall prevalence of responders: 4%
• Only 4% of NSCLCs harbour ALK translocations, and only 50% of ALK-
translocated tumours respond to ALK inhibitors:
• overall prevalence of responders: 2%
• Response to BRAF or MEK inhibition in BRAF mutant melanoma: 60%
• Response to BRAF or MEK inhibition in BRAF mutant CRC: 2%
8. Context – Personalized Medicine in Oncology
CONSIDERATION I:
Reliable preclinical models are needed to prioritize hypothesis validation in patients (clinical trials)
due to ethical, economical and social constrains.
• Understanding inter-individual tumour heterogeneity needs a reference background:
• Focus on one specific tumour type
• Pinpointing exceptions needs big numbers:
• Collect many cases
• Identifying exceptions (and the contextual mutational milieu) needs integrated
approaches with reliable outcomes:
• Multi-dimensional genomic exploration of high-quality tumour material
9. Context – Personalized Medicine in Oncology
CONSIDERATION II:
Direct transplantation of surgical specimens in immunocompromized mice can generate a high
fidelity preclinical platform for anticipation of clinical results
• Reliable simulation of phase II trials for investigational drugs
• Identification of new predictive biomarkers for approved drugs
• Multi parametric evaluation of genetic determinants for patients
stratification
• Comparative evaluation of alternative treatment protocols
11. Context – Facts & Numbers
N° of
collected
specimens 22 148 235 480 614
Oct 2008 Oct 2010 May 2011 Apr 2012 Jan 2013
CRC Evaluation of LAS LAS
banking commercial LIMS project started
started solution started working
LAS manages (starting April 2012):
• 622 surgical samples collection
• 7158 mice
• 18537 measures of tumour growth
• 1656 mice treated with 44 different protocols&schedules
• 51131 archived aliquots of biological material
15. Waterfall model
• Feasibility study
Requirements • Requirements analysis
• Requirements definition
• Define software system functions
Design • Establish an overall system architecture
• Unified Modeling Language (UML)
• Code generation
Implementation • Definition of logically separable part of the software (units)
• Unit testing done by the developer
• Integration and testing of the complete system
Verification • Testing units against the requirements as specified
• System delivered to the client
• Identification of problems
Maintenance • Errors fixed
• Performance improvements
16. Agile model
• Customer satisfaction by rapid delivery of useful
software
• Welcome changing requirements, even late in
development
• Working software is delivered frequently
• Working software is the principal measure of
progress
• Sustainable development
• Close cooperation
• Face-to-face conversation is the best form of
communication (co-location)
• Continuous attention to technical excellence and
good design
• Simplicity - the art of maximizing the amount of
work not done - is essential
• Self-organizing teams
• Regular adaptation to changing circumstances
17. Database design
• Conceptual design. The purpose is to
represent the informal requirements of an
application in terms of a conceptual schema
that refers to a conceptual data model
• Logical design. Translation of the conceptual
schema, defined in the preceding phase, into
the logical schema of the database that refers
to a logical data model
• Physical design. The logical schema is
completed with the details of the physical
implementation (file organization and indexes)
on a given DBMS. The product is called the
physical schema and refers to a physical data
model
18. The Entity Relationship model
• Conceptual data model
• Provides a series of constructs
capable of describing the data
requirements
• Easy to understand
• Independent of the criteria for the
management and organization of data
on a database system
• For every construct, there is a
corresponding graphical
representation.
• Allows to define an E-R schema
diagrammatically
19. ER constructs
• Entity
• represents classes of objects (facts, things, people, for example) that have properties in
common and an autonomous existence
• Attribute
• describes the elementary properties of entities or relationships
• Relationship
• represents logical links between two or more entities
• Cardinalities
• specified for each entity participating in a relationship
• describe the maximum and minimum number of relationship occurrences in which an
entity occurrence can participate
• for the minimum cardinality, zero or one
• for the maximum cardinality, one or many (N)
20. ER constructs
• Identifiers
• specified for each entity
• describe the concepts (attributes and/or entities) of the schema allowing the
unambiguous identification of the entity occurrences
• internal identifier (key)
• formed by one or more attributes of the entity itself
• external identifier (foreign key)
• when the attributes of an entity are not sufficient to identify its occurrences
unambiguously
• other entities need to be involved in the identification
• the entity to identify participates with cardinality equal to (1,1) into the relationship
• Generalization
• represents logical links between entities (i.e., 1 parent and one or more children)
• the parent entity is more general in the sense that it comprises child entities as a
particular case
21. Logical design
Goals
• Construction of a relational schema
• Representing correctly and efficiently all of the information described by an ER schema
Design steps
• Restructuring of the Entity-Relationship schema
• Optimization of the schema
• Translation into the logical model
Entity1 (ID1, attr_a, attr_b, …)
Entity2 (ID2, attr_x, attr_y, …)
Relationship1 (ID1, ID2, attr_r, …)
28. Querying the database
• SQL (Structured Query Language)
• designed for managing data held in a relational database management systems
• example:
SELECT barcode, mouseStrainName
FROM Mouse M, Explant E
WHERE M.barcode = E.mouseBarcode
AND status = ‘Implanted’;
• ORM (Object-relational mapping)
• programming technique for converting data between incompatible type systems in
object-oriented programming languages
• creates a "virtual object database“ used from within the programming language
• maps database table rows to objects
• allows to establish relations between those objects
30. • High-level Python Web framework that encourages rapid development
and clean, pragmatic design
• Makes it easier to build better Web apps more quickly and with less code
• The Web framework for perfectionists with deadlines
Features
• MVC architecture • Testing framework
• Object- Relation Mapper • Solid security emphasis
• Templating Language • Send emails easily
• Automatic Language • Nice support for forms
• Elegant urls • Great docs
• Unicode support • Friendly community
• Cache framework
31. Build a django project
$ django-admin.py startproject xenopatients
• command-line utility to interact with the Django project
• the actual Python package of the project
• used to import anything inside it
• indicates that this directory is a Python package
• settings/configuration for the project
• URL declarations
• an entry-point for WSGI-compatible webservers to
serve your project
32. Run server
$ ./manage.py runserver
Validating models...
0 errors found
March 07, 2013 - 15:50:53
Django version 1.5, using settings ‘xenopatients.settings'
Development server is running at http://127.0.0.1:8000/
Quit the server with CONTROL-C.
33. Create application
$ python manage.py startapp xenos
• application belonging to the Django project
• indicates that this directory is a Python package
• defines python classes mapped on database tables
• simple routines to check the operation of the code
• defines a “type” of Web page to serve a specific
function with a specific template
• each view is represented by a simple Python function
34. Define the model
Edit the file /xenos/models.py
class Mice(models.Model):
barcode = models.BigIntegerField(primary_key=True, editable=False)
birth_date = models.DateField(db_column= 'birthdate', blank=True)
death_date = models.DateField(db_column= 'deathdate', blank=True)
gender = models.CharField(max_length=1)
status = models.CharField(max_length=20)
id_mouse_strain = models.ForeignKey(‘Mouse_strain’, blank=True,
db_column='id_mouse_strain')
def __unicode__(self):
return self.barcode
class Mouse_strain(models.Model):
id_strain = models.BigIntegerField(primary_key=True, editable=False)
mouse_strain_name = models.CharField(max_length=45, unique=True)
description = models.TextField()
linkToDoc = models.CharField(max_length=80)
def __unicode__(self):
return self.mouse_strain_name
35. Define the urls and views
Edit the file /xenos/urls.py
urlpatterns = patterns('',
(r'^$', views.index),
(r'^miceloading/$', views.miceLoading),
(r'^miceStatus/$', views.changeStatus),
…
Edit the file /xenos/views.py
@login_required
def index(request):
if request.method == 'GET':
name = request.user.username
return render_to_response('index.html', {'name':name},
RequestContext(request)) …
36. Activate the admin site
Edit the file /xenopatients/urls.py
from django.conf.urls.defaults import *
# Uncomment the next two lines to enable the admin:
from django.contrib import admin
admin.autodiscover()
urlpatterns = patterns('',
# Uncomment the next line to enable the admin:
(r'^admin/', include(admin.site.urls)),
38. References
• Software Engineering
• I. Sommerville (2010) “Software Engineering (9th Edition)”
• I. Sommerville (2007) “Ingegneria del software”
• R. Miles, K. Hamilton (2006) “Learning UML 2.0”
• M. Fowler (2010) “UML distilled. Guida rapida al linguaggio di modellazione standard”
• Database
• C. Coronel, S. Morris, P. Rob (2012) “Database Systems: Design, Implementation, and
Management”
• P. Atzeni, S. Ceri, S. Paraboschi, R. Torlone (2009) “Basi di dati – Modelli e linguaggi di
interrogazione”
• Python & Django
• A. Martelli (2006) “Python in a Nutshell, Second Edition”
• M. Lutz (2009) “Learning Python: Powerful Object-Oriented Programming”
• M. Dawson (2010) “Python Programming for the Absolute Beginner, 3rd Edition”
• Django website https://www.djangoproject.com/
• A. Holovaty, J. Kaplan-Moss (2009) “The Definitive Guide to Django: Web Development
Done Right”
• M. Beri (2009) “Sviluppare applicazioni web con Django”
39. References (context)
• Personalized medicine in oncology
• Hait WN, Cancer Discov 1, 383 (2011).
• MacConaill LE et al., Cancer Discov 1, 297 ( 2011).
• Haber Da, Gray NS, Baselga J, Cell 145, 19 (2011).
• Unmet needs and preclinical models
• de Bono JS, Ashworth A, Nature 467, 543 (2010).
• Tentler JJ et al., Nat Rev Clin Oncol 9, 338 (2012).
• Our work
• Baralis E et al., J Med Systems ( 2012).
• Migliardi G et al., Clin Cancer Res 18, 2515 ( 2012).
• Bertotti A et al., Cancer Discov 1, 508 (2011).
• Galimi F et al., Clin Cancer Res 17, 3146 ( 2011).